Clinical Trials for Unresectable Pancreatic Ductal Adenocarcinoma

Find clinical trials for unresectable pancreatic ductal adenocarcinoma. Discover research opportunities and treatment options in your area.

6 Active Trials Found

Showing 6 trials on this page

Page 1 of 1

CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer

NCT ID: NCT05685602

This clinical trial is studying a new treatment approach for patients with advanced pancreatic cancer that cannot be surgically removed or has spread to other parts of the body. The researchers are...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States, Bethesda, Maryland, United States +28 more

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

NCT ID: NCT06626256

This clinical trial is studying a new treatment called STIL101 for injection, designed to help patients with certain types of advanced cancers, including pancreatic, colorectal, renal cell, cervica...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States

Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer

NCT ID: NCT04821284

This clinical trial is studying a new treatment approach for pancreatic cancer that combines standard chemotherapy with a technique called sonoporation. Sonoporation uses ultrasound waves and tiny ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bergen, , Norway, Philadelphia, Pennsylvania, United States

Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer

NCT ID: NCT06454383

This clinical trial is studying a combination of two medications, gemcitabine and leflunomide, to see if they can be safely used together to treat patients with advanced pancreatic cancer that cann...

Recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States

Targeted Pathway Inhibition in Patients With Pancreatic Cancer

NCT ID: NCT04005690

This clinical trial is investigating how well certain medications work for patients with pancreatic cancer, specifically those with advanced or metastatic forms of the disease. The drugs being test...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Portland, Oregon, United States

Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer

NCT ID: NCT04887805

This clinical trial is studying a combination of two medications, lenvatinib and pembrolizumab, to see if they can help patients with advanced pancreatic cancer that cannot be surgically removed. L...

Recruiting

Phase: PHASE2 Type: interventional Locations: Duarte, California, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions